]>
IRCT20200113046115N1 IRCT 2020-03-21 Shiraz University of Medical Sciences The Effect of Matricaria Chamomile and Rhus Coriaria on some Uterine Fibroma Symptoms in Women Comparison of the Effect of Matricaria Chamomile and Rhus Coriaria on Some Uterine Fibroma Symptoms in Women with fibroid diseases 2020-04-20 anticipated 183 Complete https://irct.ir/trial/45154 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Divide the block into three groups A, B, C and each letter is randomly assigned to the sumac, chamomile, and placebo group. The letters are then grouped into 6 (1: ABC, 2: ACB, 3: BAC, 4: BCA, 5: CBA, 6: CAB) and A number is randomly selected from 1 to 6, indicating the order of allocation of the first three individuals in the groups. Again, 1 to 6 numbers are selected at random. The order of assignment of individuals to groups is specified at each time, Blinding description: In this study, the capsules of the same size and color in dark color packages will be prepared by the pharmacology unit of Shiraz University of Medical Sciences.Medicines with specific codes that only the pharmacist is aware of and The researcher is the prescriber and the participant is unaware.The data analyzer is also uninformed. In this study, only the pharmacist is aware of the type of medication. 3 Uterine Fibroma. Intervention 1: 500 mg Matricaria chamomile capsule standardized by Barij Essence Company and packaged by Shiraz University of Medical Sciences Pharmacology Unit and medication duration three times daily for two menstrual cycles for the first seven days of menstruation. Intervention 2: The 500 mg Sumac Rus Coriaria capsule is standardized and packaged by the Shiraz University of Medical Sciences Pharmacology Unit and is administered three times daily during the first seven menstrual cycles of the menstrual cycle. Intervention 3: Control group: 500 mg placebo capsule containing cellulose powder packaged by Shiraz University of Medical Sciences pharmacology unit and drug administration three times daily during two menstrual cycles for the first seven days of menstruation. Yes - There is a plan to make this available What will be shared: After analyzing the data and after Identifying people, part of the data will be available as a pdf file When: 3 Month After Finish of Study To whom: Researchers are working in university centers Conditions: No data can be used under any circumstances Where to obtain: Referring to Professor Marziyeh Akbarzadeh How to obtain: Visit the Faculty of Nursing and Midwifery of Professor Akbarzadeh's office Comments:
public Marziyeh Akbarzadeh
Faculty of Midwifery and Nursing, Namazi Square
Shiraz Iran (Islamic Republic of) 71345-1978 +98 71 1647 4254 AKBARZADEHMARZIEH@YAHOO.COM Shiraz University of Medical Sciences scientific Maryam Jafari
6 Block, Eram Dormitory, Eram sq
Shiraz Iran (Islamic Republic of) 111111111 +98 77 3425 0884 maryam.jafari9170@gmail.com Shiraz University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Iran (Islamic Republic of) Women with Fibroid Disease Confirmed by a Gynecologist Women who are willing to Cooperate and Submit Their Written Consent Not taking any Hormonal Medication The patient is not involved in any other diseases, including thyroid disease, endometriosis, adenomyosis and malignancies, etc. (Based on patient records) Don't be pregnant Don't be lactating Not Allergic to Chamomile and Sumac and Mefenamic Acid No History of Gastrointestinal, liver, Brain and Kidney Disease and Coagulation disorders Body Mass Index 19-29 Age range 20-49 years No history of prolonged constipation 20 years 50 years Female Treatment - Drugs Treatment - Drugs Treatment - Drugs 500 mg Matricaria chamomile capsule standardized by Barij Essence Company and packaged by Shiraz University of Medical Sciences Pharmacology Unit and medication duration three times daily for two menstrual cycles for the first seven days of menstruation. The 500 mg Sumac Rus Coriaria capsule is standardized and packaged by the Shiraz University of Medical Sciences Pharmacology Unit and is administered three times daily during the first seven menstrual cycles of the menstrual cycle. Control group: 500 mg placebo capsule containing cellulose powder packaged by Shiraz University of Medical Sciences pharmacology unit and drug administration three times daily during two menstrual cycles for the first seven days of menstruation. Moderate to severe pain. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Pain measurement by using visual analogue scale. Bleeding includes menorrhagia and menometrorrhagia. Timepoint: Before intervention and 2 months after intervention. Method of measurement: Using a pictorial blood assessment chart, patient with the bleeding score higher than 100 will study The pre-study and post-study scores will be compared. Frequent urination more than 7 times a day. Timepoint: Before intervention and 2 months after intervention. Method of measurement: urination will be entered into the study more than 7 times a day and the number of urination before and after the intervention will be questioned and recorded and compared by the patient. Shiraz University of Medical Sciences Approved 2019-12-31 Ethics Committee of shiraz university of medical science Central building of Shiraz university of Medical Science ,Zand Ave,Across Palestin Street Shiraz Fars Iran (Islamic Republic of)